Staff Reporter
Published:
Biologic therapeutic market to hit $794.5b by 2029
Thanks to the demand for monoclonal antibodies, gene and cell therapies, and vaccines.
The biologic therapeutic market is projected to reach $794.5b by 2029 at a compound annual growth rate of 9.7%, according to BCC Research.
The sector’s expansion is attributed to a surge in demand for monoclonal antibodies, gene and cell therapies, and vaccines.
“Biologics are central to the shift toward personalised medicine, where treatments are tailored to individual genetic profiles,” the report said.
Moreover, chronic diseases such as diabetes, cancer, and arthritis, due to an ageing global population, are driving market growth.
Read Here
Advertise
Sign Up
